Regencell Bioscience Holdings Limited Profile
Industry
Drug Manufacturers - Specialty & GenericSector
HealthcareNumber of Employees
12Regencell Bioscience Holdings's Business Model
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
About Regencell Bioscience Holdings
Website: https://www.regencellbioscience.com
CEO (Chief Executive Officer): Mr. Yat-Gai Au
IPO date: 2021-07-16
Contact
Country: HK
Address: First Commercial Building
City: Causeway Bay
State: None
Phone: 852 2155 0823
Zip Code: KY1-1107
Other
CIK: 0001829667
ISIN: KYG7487R1002
CUSIP: G7487R100
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
